parches glp 1 BoletínDeprensa El Invima informa sobre la comercialización ilegal de los GLP-1 PATCHES (LUMESSA), promocionados en internet como método para bajar de peso sin registro sanitario en Colombia. La entidad advierte que Parches Kind GLP-1 Weightless Patches

Shulman A, Peltonen M, Sjostrom CD, et al

A systematic review found that GLP-1 receptor agonists significantly reduced albuminuria, a marker of kidney damage, and slowed the decline in kidney function, particularly in patients with early-stage renal disease

Food & Drug Administration, Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity (2024)

This content is for informational purposes only and should not be viewed as a substitute for medical advice

For patients currently using injectable GLP-1 medications , recommended injection sites include the abdomen (at least 2 inches from the navel), the front of the thighs, and the upper arms